文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

基于理赔数据的衰弱测量在老年癌症患者中的评估:回顾性队列研究

Evaluation of claims-based frailty measurements in older patients with cancer: a retrospective cohort study.
PubMed 文献 · Age Ageing · 2025-01-01

该回顾性队列研究纳入5176例≥65岁接受癌症治疗的日本患者,基于诊断代码计算电子衰弱指数(eFI)和退伍军人事务部衰弱指数(VA-FI),评估其与死亡及复合结局(照护需求等级下降、入住长期照护机构或死亡)的关联。Kaplan-Meier曲线显示衰弱指数与研究结局显著相关,最高衰弱组复合结局风险显著升高(eFI HR 2.59,95%CI 1.66-4.06;VA-FI HR 2.45,95%CI 1.02-5.91)。结论提示较高衰弱水平与老年癌症患者复合结局风险增加相关。

要点

  • 基于理赔诊断代码计算的eFI和VA-FI与老年癌症患者不良结局显著相关。
  • 最高衰弱组复合结局风险较最低组显著升高,eFI HR 2.59,VA-FI HR 2.45。
  • 衰弱水平越高,各研究结局发生率呈显著上升趋势。

核心结论

  • 较高衰弱水平与老年癌症患者复合结局(照护需求等级下降、入住长期照护机构或死亡)风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入5176例≥65岁在医院接受癌症治疗的患者。
  • 基于诊断代码计算电子衰弱指数(eFI)和退伍军人事务部衰弱指数(VA-FI)。

主要发现

  • Kaplan-Meier生存曲线显示eFI和VA-FI与各研究结局显著相关。
  • 最高衰弱组与最低组相比,复合结局HR为2.59(95%CI 1.66-4.06,eFI)和2.45(95%CI 1.02-5.91,VA-FI)。
  • 趋势检验表明衰弱水平越高,各结局发生率显著增加。

临床怎么用

  • 本研究提示基于理赔数据的衰弱测量或可应用于肿瘤照护场景,用于识别高风险老年癌症患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is associated with poor outcomes in older adults with cancer. Several efforts have been made to assess frailty using the administrative claims data based on the number of clinical diagnosis codes, yet the literature reporting on this is scarce. This study aimed to evaluate the impact of frailty measures using administrative databases in Japan. DESIGN: A retrospective cohort study. SETTING AND PARTICIPANTS: 5176 patients with cancer aged ≥65 years who underwent cancer treatment in hospitals. METHODS: The Electronic Frailty Index (eFI) and Veterans Affairs Frailty Index (VA-FI), based on diagnostic codes recorded were calculated. We plotted Kaplan-Meier survival curves and calculated hazard ratios (HR) using Cox regression analyses. The primary outcome was mortality, whereas the composite secondary outcome included a decline in care-need level, admission to a long-term care facility (LTCF) or mortality. RESULTS: The Kaplan-Meier survival curve demonstrated a significant association between the eFI and VA-FI and each research outcome. Compared to the lowest frailty group, the highest frailty group exhibited an HR of 2.59 [95% confidence interval (CI), 1.66-4.06] for eFI and 2.45 (95%CI, 1.02-5.91) for VA-FI in relation to a decline in care-need level, an LTCF admission and mortality. The trend test indicated a significant increase in the rate of each outcome with higher frailty levels. CONCLUSIONS: Higher frailty levels are associated with an increased risk of composite outcomes in older adults with cancer. This study suggests the potential application of frailty measurements in oncology care settings.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Kayo H, Yusuke K, Sakiko I, et al. Evaluation of claims-based frailty measurements in older patients with cancer: a retrospective cohort study. Age Ageing. 2025. PMID: 39895246. doi:10.1093/ageing/afaf015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。